Updated August 17, 2026
CellCarta offers a full range of validated genomic assays. With sites accredited by CAP and CLIA certifications, we provide the highest standard of quality. Our team continually develops new biomarker assays and has experience with several commercial assays. Contact us for any custom development.
Updated August 17, 2026
CellCarta offers a full range of validated genomic assays. With sites accredited by CAP and CLIA certifications, we provide the highest standard of quality. Our team continually develops new biomarker assays and has experience with several commercial assays. Contact us for any custom development.
Updated August 10, 2026
CellCarta offers a full range of validated human IHC, multiplex IHC (mIHC) and multiplex immunofluorescence (mIF) assays. With sites accredited by CAP and CLIA certifications, we provide the highest standard of quality. Our team continually develops new biomarker assays and has experience with hundreds more than represented in the brochure.
Contact us for any custom development!
Updated August 10, 2026
CellCarta offers a full range of validated human IHC, multiplex IHC (mIHC) and multiplex immunofluorescence (mIF) assays. With sites accredited by CAP and CLIA certifications, we provide the highest standard of quality. Our team continually develops new biomarker assays and has experience with hundreds more than represented in the brochure.
Contact us for any custom development!
May 25, 2026
May 25, 2026
April 10, 2026
CellCarta has deep expertise in developing flow cytometry panels for clinical use and provides the highest standard of quality with CAP accreditated and CLIA certified sites.
To support the monitoring of all immune cell populations, we catered a list of specific panels for both your whole blood and cryopreserved PBMC samples.
Off-the-shelf (OTS) panels were pre-developed and validated at all global sites with the same level of validation and provide the fastest runway to clinical sample analysis, and catalogue panels were pre-developed and validated at specific sites and can be rapidly deployed upon request.
April 10, 2026
CellCarta has deep expertise in developing flow cytometry panels for clinical use and provides the highest standard of quality with CAP accreditated and CLIA certified sites.
To support the monitoring of all immune cell populations, we catered a list of specific panels for both your whole blood and cryopreserved PBMC samples.
Off-the-shelf (OTS) panels were pre-developed and validated at all global sites with the same level of validation and provide the fastest runway to clinical sample analysis, and catalogue panels were pre-developed and validated at specific sites and can be rapidly deployed upon request.
May 16, 2025
CellCarta has a team of regulatory experts that can help you navigate the global regulations to deploy your clinical assay at a global scale.
May 16, 2025
CellCarta has a team of regulatory experts that can help you navigate the global regulations to deploy your clinical assay at a global scale.
